TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,652 | -70.3% | 309 | -70.1% | 0.00% | -100.0% |
| Q2 2023 | $39,258 | – | 1,035 | +5988.2% | 0.00% | – |
| Q1 2023 | $0 | -100.0% | 17 | -84.1% | 0.00% | – |
| Q3 2022 | $3,000 | -40.0% | 107 | -23.6% | 0.00% | – |
| Q2 2022 | $5,000 | – | 140 | +3400.0% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 4 | -88.6% | 0.00% | – |
| Q4 2021 | $2,000 | – | 35 | +600.0% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 5 | -99.8% | 0.00% | -100.0% |
| Q2 2021 | $174,000 | +35.9% | 2,424 | +39.4% | 0.01% | +150.0% |
| Q1 2021 | $128,000 | +456.5% | 1,739 | +457.4% | 0.00% | +100.0% |
| Q4 2020 | $23,000 | +9.5% | 312 | -19.8% | 0.00% | – |
| Q3 2020 | $21,000 | +61.5% | 389 | +100.5% | 0.00% | -100.0% |
| Q2 2020 | $13,000 | -13.3% | 194 | -19.2% | 0.00% | 0.0% |
| Q1 2020 | $15,000 | -91.4% | 240 | -87.9% | 0.00% | -92.9% |
| Q4 2019 | $174,000 | +2385.7% | 1,980 | +1941.2% | 0.01% | – |
| Q3 2019 | $7,000 | -97.8% | 97 | -97.5% | 0.00% | -100.0% |
| Q2 2019 | $325,000 | +371.0% | 3,810 | +500.9% | 0.02% | +450.0% |
| Q1 2019 | $69,000 | -90.0% | 634 | -92.2% | 0.00% | -92.0% |
| Q4 2018 | $687,000 | +370.5% | 8,118 | +447.0% | 0.05% | +354.5% |
| Q3 2018 | $146,000 | -29.8% | 1,484 | -17.6% | 0.01% | -8.3% |
| Q2 2018 | $208,000 | -62.0% | 1,802 | -67.5% | 0.01% | -74.5% |
| Q1 2018 | $548,000 | +74.5% | 5,549 | +85.3% | 0.05% | +14.6% |
| Q4 2017 | $314,000 | +157.4% | 2,995 | +176.8% | 0.04% | +310.0% |
| Q3 2017 | $122,000 | -52.9% | 1,082 | -51.3% | 0.01% | -61.5% |
| Q1 2017 | $259,000 | +12850.0% | 2,224 | +11020.0% | 0.03% | – |
| Q4 2016 | $2,000 | -88.9% | 20 | -87.7% | 0.00% | -100.0% |
| Q3 2016 | $18,000 | -56.1% | 162 | -42.6% | 0.00% | -50.0% |
| Q2 2016 | $41,000 | +95.2% | 282 | +94.5% | 0.00% | +33.3% |
| Q1 2016 | $21,000 | +320.0% | 145 | +314.3% | 0.00% | – |
| Q3 2015 | $5,000 | +150.0% | 35 | +191.7% | 0.00% | – |
| Q2 2015 | $2,000 | -96.5% | 12 | -97.9% | 0.00% | -100.0% |
| Q4 2013 | $57,000 | +612.5% | 576 | +476.0% | 0.01% | +900.0% |
| Q3 2013 | $8,000 | -61.9% | 100 | -73.8% | 0.00% | -50.0% |
| Q2 2013 | $21,000 | – | 382 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ISZO CAPITAL MANAGEMENT LP | 1,104,168 | $154,849,000 | 80.27% |
| Consonance Capital Management LP | 378,372 | $53,063,000 | 7.89% |
| Moab Capital Partners | 93,133 | $13,061,000 | 6.27% |
| Greywolf Capital Management LP | 277,936 | $38,978,000 | 5.77% |
| Perceptive Advisors | 301,333 | $42,260,000 | 4.15% |
| Valentine Capital Asset Management, Inc. | 141,270 | $19,812,000 | 3.81% |
| Raging Capital Management, LLC | 253,236 | $35,514,000 | 3.78% |
| Ativo Capital Management LLC | 18,058 | $2,532,000 | 1.10% |
| Geduld E E | 8,000 | $1,122,000 | 0.70% |
| Assured Investment Management LLC | 192,389 | $26,981,000 | 0.46% |